Yan Liu1, Ruben Hoya-Arias, Stephen D Nimer. Show Affiliations » 1. Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Abstract
Entities: Gene
Mesh: See more » AnimalsApoptosis/geneticsCell Cycle/geneticsCell Transformation, NeoplasticCellular ReprogrammingCyclin-Dependent Kinase Inhibitor p16/antagonists & inhibitorsCyclin-Dependent Kinase Inhibitor p16/geneticsCyclin-Dependent Kinase Inhibitor p16/metabolismCyclin-Dependent Kinase Inhibitor p21/geneticsCyclin-Dependent Kinase Inhibitor p21/metabolismFibroblasts/physiologyGene Expression RegulationGenomic InstabilityHematopoietic Stem Cells/physiologyHumansInduced Pluripotent Stem Cells/metabolismInduced Pluripotent Stem Cells/pathologyMiceMutagenesis, InsertionalProto-Oncogene Proteins c-mdm2/geneticsProto-Oncogene Proteins c-mdm2/metabolismTumor Suppressor Protein p53/antagonists & inhibitorsTumor Suppressor Protein p53/geneticsTumor Suppressor Protein p53/metabolism
Substances: See more » CDKN1A protein, humanCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53MDM2 protein, humanProto-Oncogene Proteins c-mdm2
Year: 2009 PMID: 19881523 DOI: 10.1038/cr.2009.121
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617